Health and Medical News LONDON (Reuters) - AstraZeneca's board said on Friday it had rejected an improved $106 billion takeover offer from U.S. drugmaker Pfizer, saying the bid which was announced just hours ago undervalued the firm. "Pfizer's proposal would...
by via @ Health and Medical News
by via @ Health and Medical News